Home LiteratureArticle Details
PMID: 545725 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Genetic and adaptive differences in the expression of drug resistance in hybrid cells.

Somatic cell genetics ·Vol. 5 ·No. 6 ·1979-11-00 ·Pages 793-808

Harris M

Abstract

Hybrids between Chinese hamster cells were isolated and maintained in media that were selective or nonselective for markers present in the parent cells (HGPRT and TK deficiencies, respectively). Segregation frequencies for resistance to azaguanine (AZG), thioguanine (THG), or bromodeoxyuridine (BrdU) could be enhanced for some groups of hybrids if the stock cells were maintained under nonselective conditions rather than in HAT medium. In these populations the expression of resistance was dominant or codominant even though marker patterns were recessive for the same cells in HAT. Clonal analysis showed that enhancement took place by adaptive shifts rather than by variation and selection. Segregation frequencies in hybrids were also found to differ significantly between clones isolated by replicate fusions of any two parental cell types. The basis for this heterogeneity is unknown and deserves further study.

MeSH Terms
Animals Azaguanine/pharmacology Bromodeoxyuridine/pharmacology Cell Line Cricetinae Cricetulus Drug Resistance Genes, Dominant Hybrid Cells/physiology Lung Phenotype Thioguanine/pharmacology
Chemicals
Thioguanine Bromodeoxyuridine Azaguanine
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Harris M
Article Info
Journal
Somatic cell genetics
Abbr.
Somatic Cell Genet
ISSN
0098-0366
Published
1979-11-00
Pages
793-808
Language
English
Region
United States
NLM ID
7506054
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com